Surgical therapy of peri-implantitis with adjunctive hydroxyapatite and enamel matrix derivative: a 1-year retrospective case series

Abstract

This case series retrospectively investigated the one-year surgical outcome of regenerative peri-implantitis therapy using a hydroxyapatite (HA) bone substitute material in combination with enamel matrix derivate (EMD) and collagen membrane for guided bone regeneration (GBR). Data-sheets of patients were screened to detect patients who received identical regenerative peri-implantitis-therapy with surface decontamination and GBR applying HA, EMD and a collagen membrane under broad-spectrum antibiotic regime. For inclusion, information on pre- and postoperative clinical and radiographic parameters (probing pocket depth (PPD), bleeding on probing (BOP), suppuration (SUPP) and the radiological bone level (RBL)) had to be available for statistical analysis. Data of a total of 11 patients (20 implants) were extracted out of 202 (336). All implants were still in function after one year. Bone defects decreased by an average of 1.3 mm mesially and 0.9 mm distally, respectively. Mean PPD was reduced from 4.9 mm to 2.7 mm. BOP decreased from 90% to 20%. Suppuration decreased from 65% to 0%. Based on the success criteria applied, 15 of the 20 (75%) implants included were considered as successfully treated after 1 year. Regenerative peri-implantitis therapy according to the presented concept showed promising clinical and radiographic outcomes after one year. To estimate the beneficial effects of the combined use of HA, EMD and collagen membranes, further long-term investigations with a control group are needed.
 Accepted for publication: January 7, 2022
 Published online: January 12, 2022